Predoctoral Contract for Developing Novel Therapies Targeting DSTYK in Lung Cancer

This predoctoral position offers an opportunity to contribute to pioneering research in lung cancer therapy by developing targeted treatments against the DSTYK protein. The project spans from designing and characterizing novel inhibitors to functional validation, aiming to advance precision oncology. The successful candidate will work under expert supervision in a dynamic research environment focused on translational medicine. The role is ideal for motivated doctoral students with a strong background in biomedical sciences or related fields, seeking to make an impact in cancer research.

• Design and synthesize novel inhibitors targeting the DSTYK protein in lung cancer cells.
• Characterize the biochemical and functional properties of the developed inhibitors.
• Conduct in vitro and in vivo experiments to validate the efficacy and safety of the inhibitors.
• Collaborate with interdisciplinary teams to integrate findings into broader therapeutic strategies.
• Publish research findings in high-impact scientific journals and present results at conferences.
• Contribute to the development of a pipeline for potential clinical translation of the inhibitors.